On Friday, April 1, 2022 the Oregon Health Authority (OHA) released revised proposed Oregon Administrative Rules (OARs) for psilocybin products, testing, and training programs. This post will focus on the rules related to products. Readers of this blog will recall we reviewed an early draft of these administrative rules back in February. Unsurprisingly, the rules
Ketamine clinics are run by various provider types in the United States. In some states, mid-level practitioners (e.g., Nurse Practitioners and Physician Assistants) can practice independently. In other states, such providers can only work independently if they are supervised or overseen by a physician. However, the question then becomes whether any physician can run a
Over the past few years, access to mushrooms containing psilocybin has become much easier in Vancouver, British Columbia, Canada. There are now four dispensaries that sell psilocybin mushrooms in the city, including two locations downtown, one located on Commercial Drive, and one located on the Downtown Eastside. The prevalence of these dispensaries has made it
The outlook for psychedelics legalization in Washington State, and specifically psilocybin legalization, looks promising and continues to evolve at a rapid pace. The Spokane Bar Association recently held a seminar on emerging issues in the Washington psychedelic ecosystem. In October, Seattle became the largest in the United States to decriminalize psychedelics. As the second largest
Time for another Oregon psilocybin licensing update. In this post we will explain what the Licensing Subcommittee covered in its recent meeting on March 3, 2022. Licensing Subcommittee Schedule and Timelines The Licensing Subcommittee meets every month to develop licensing requirements for psilocybin businesses and professionals. So far, it has developed recommendations regarding informed consent
RICO (or the federal Racketeer Influenced and Corrupt Organizations Act) has been a thorn in the foot for cannabis companies since, well, the dawn of cannabis companies. RICO will be just as annoying for psychedelics companies. Today I will explain what RICO is and why RICO and psychedelics will have a rocky relationship. What is
Ketamine clinic providers engaged in the off label application of ketamine for patient treatment are nothing new in U.S. healthcare. What is relatively new is that many “psychedelics” companies are trying to infiltrate the ketamine clinic scene. These companies hope to gain a foothold, then expand into a fuller suite of psychedelic treatment services once
In this post, we’ll discuss Oregon psilocybin facilitator exam recommendations to date under Measure 109. Competency exams are common for professions such as therapists, public school teachers and nurses. For instance, every state has a Nurse Practice Act to protect public safety by requiring nurses to pass a certification exam prior to practicing as a
When a person ingests psilocybin, in any form, the effects can be unpredictable. Some people will feel no different than normal. Others find themselves in a state of emotional reflection, ranging from light to deep introspection. Yet some experience moments of fear, anxiety, or reliving past trauma. How may a facilitator assist a person experiencing
We’ve discussed at length the DEA’s process for seeking religious exemptions to the Controlled Substances Act (CSA). You can read about that in my posts linked at the bottom of this one. Critics of the religious exemption petition process claim that the DEA rarely, if ever, responds to petitions. They also complain that they are
